ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P 500
5,431.60
-0.04%
US Tech 100
19,168.00
0.52%
Dow Jones
38,589.16
-0.15%
Brent Oil
82.275
0.00%
Bitcoin
66,136.51
0.20%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. UK
  5. LSE

  6. Adl Partner Sa (0N5X) Quote

Adl Partner Sa

Adl Partner Sa (0N5X)

LSE
16.00
0.00
(0.00%)
Closed June 15 11:30AM
Delayed by 15 minutes

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Key stats and details

Current Price
16.00
Bid
0.00
Ask
0.00
Volume
3
0.00 Day's Range 0.00
16.00 52 Week Range 16.00
Market Cap
147.822M
Previous Close
16.00
Open
-
Last Trade
3
@
2917.403
(O)
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
1
Shares Outstanding
4,164,000
Dividend Yield
-
PE Ratio
11.88
Earnings Per Share (EPS)
2.99
Revenue
200.67M
Net Profit
12.44M

About Adl Partner Sa

Sector
Employment Agencies
Industry
Employment Agencies
Website
www.dekuple.com
Headquarters
Montreuil, Seine-saint-denis, Fra
Founded
1970
Adl Partner Sa is listed in the Employment Agencies sector of the London Stock Exchange with ticker 0N5X. The last closing price for Adl Partner was 16.00 €. Over the last year, Adl Partner shares have traded in a share price range of 16.00 € to 16.00 €.

Adl Partner currently has 4,164,000 shares outstanding. The market capitalization of Adl Partner is 147.82 € million. Adl Partner has a price to earnings ratio (PE ratio) of 11.88.

0N5X Latest News

More News

Dékuple: COMBINED GENERAL MEETING ON 14 JUNE 2024

Dékuple: COMBINED GENERAL MEETING ON 14 JUNE 2024 COMBINED GENERAL MEETING ON 14 JUNE 2024_____ Dividend of €1.04 per share, to be paid out on 21 June 2024 Modification of the description...

June 14 2024
GlobeNewswire Inc.

Dékuple : ACTIVITÉ DU 1ER TRIMESTRE 2024

Dékuple : ACTIVITÉ DU 1ER TRIMESTRE 2024   ACTIVITÉ DU 1ER TRIMESTRE 2024_____ Chiffre d’affaires : 52,0 M€ (+ 8,5 %) Marge brute : 41,8 M€ (+ 5,1 %)Croissance solide de la marge brute des...

May 27 2024
GlobeNewswire Inc.

Dékuple : Assemblée générale mixte du 14 juin 2024 / Modalités de mise à disposition des documents préparatoires

Dékuple : Assemblée générale mixte du 14 juin 2024 / Modalités de mise à disposition des documents préparatoires  Assemblée générale mixte du 14 juin 2024 Modalités de mise à disposition des...

May 24 2024
GlobeNewswire Inc.

DÉKUPLE: Communiqué relatif à la conclusion de trois engagements collectifs de conservation d’actions de la société

DÉKUPLE: Communiqué relatif à la conclusion de trois engagements collectifs de conservation d’actions de la société Communiqué relatif à la conclusion de trois engagements collectifs de...

May 22 2024
GlobeNewswire Inc.

DÉKUPLE: MISE À DISPOSITION DU RAPPORT FINANCIER ANNUEL 2023

DÉKUPLE: MISE À DISPOSITION DU RAPPORT FINANCIER ANNUEL 2023 MISE À DISPOSITION DU RAPPORT FINANCIER ANNUEL 2023 Paris, le 18 avril 2024 (19h00) - Le Groupe DÉKUPLE, expert du data marketing...

April 18 2024
GlobeNewswire Inc.

DEKUPLE - 2023 FULL-YEAR EARNINGS: further year of strong growth in line with the “Ambition 2025” plan

DEKUPLE - 2023 FULL-YEAR EARNINGS: further year of strong growth in line with the “Ambition 2025” plan 2023 FULL-YEAR EARNINGS: further year of strong growth in line with the “Ambition 2025”...

March 29 2024
GlobeNewswire Inc.

DÉKUPLE: 2023 Net sales: €199.7m (+10.2%)

DÉKUPLE: 2023 Net sales: €199.7m (+10.2%) Net sales: €199.7m (+10.2%) Gross margin: €161.2m (+11.4%)Sustained growth for digital marketing, with its gross margin up +38.6% Paris, 26 February 2024...

February 26 2024
UK Regulatory

DÉKUPLE : Chiffre d’affaires 2023 : 199,7 M€ (+ 10,2 %)

DÉKUPLE : Chiffre d’affaires 2023 : 199,7 M€ (+ 10,2 %) Chiffre d’affaires : 199,7 M€ (+ 10,2 %) Marge brute : 161,2 M€ (+ 11,4 %)Croissance soutenue du marketing digital avec une marge brute en...

February 26 2024
UK Regulatory

ADLPartner : Déclaration des transactions sur actions propres réalisées du 8 au 12 janvier 2024

ADLPartner : Déclaration des transactions sur actions propres réalisées du 8 au 12 janvier 2024 ADLPartnerSociété Anonyme au capital de 6 478 836 euros3, avenue de Chartres - 60500...

January 15 2024
GlobeNewswire Inc.

Dékuple : Bilan semestriel du contrat de liquidité entre DÉKUPLE et NATIXIS ODDO BHF

Dékuple : Bilan semestriel du contrat de liquidité entre DÉKUPLE et NATIXIS ODDO BHF Bilan semestriel du contrat de liquidité entre DÉKUPLE et NATIXIS ODDO BHF Paris, le 12 janvier 2024...

January 12 2024
GlobeNewswire Inc.
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000DE
400161616116DE
1200161616116DE
2600161616116DE
5200161616216DE
156001616163216DE
260001616162616DE

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
KAVLKaival Brands Innovations Group Inc
$ 5.96
(338.24%)
70.99M
LRHCLa Rosa Holdings Corporation
$ 1.165
(90.61%)
40.6M
SVMHSRIVARU Holding Ltd
$ 0.227586
(49.24%)
276.03M
BRFHBarfresh Food Group Inc
$ 3.03
(38.36%)
247.31k
NNENano Nuclear Energy Inc
$ 9.37
(32.53%)
1.77M
NXLNexalin Technologies Inc
$ 0.89
(-35.52%)
3.93M
INABIN8bio Inc
$ 1.095
(-34.82%)
4.92M
QXOQXO Inc
$ 134.10
(-34.71%)
142.29k
GANXGain Therapeutics Inc
$ 1.24
(-34.39%)
3.09M
KYTXKyverna Therapeutics Inc
$ 9.52
(-34.07%)
4.31M
NVDANVIDIA Corporation
$ 131.88
(1.75%)
309.34M
SVMHSRIVARU Holding Ltd
$ 0.227586
(49.24%)
276.03M
KITTNauticus Robotics Inc
$ 0.1921
(19.69%)
165.83M
CRKNCrown Electrokinetics Corporation
$ 0.0582
(-21.35%)
136.77M
SQQQProShares UltraPro Short QQQ
$ 8.43
(-1.29%)
112.46M

Discussion

View Full Feed
cjstocksup cjstocksup 30 seconds ago
https://x.com/TheBabylonBee/status/1801694159184474598
DesertDrifter DesertDrifter 32 seconds ago
https://scontent-lax3-1.xx.fbcdn.net/v/t39.30808-6/448216247_913829864121831_5099054181782173363_n.jpg?_nc_cat=104&ccb=1-7&_nc_sid=5f2048&_nc_ohc=3HwWTfeSSfAQ7kNvgEufKXK&_nc_ht=scontent-lax3-1.xx&oh=00_AYDSvVRQgPqbSYmIxgwCwvRX61YOspitlG4nYRzfq7r3Ng&oe=6673CFA2

https://scontent-lax3-2.
Steady_T Steady_T 1 minute ago
Your opinion on what other people think about what I write is irrelevant.
AVXL
just Scottie just Scottie 2 minutes ago
Yeah! It’s some strong stuff going on.
I’m hoping they pump this before they decide to split
SONX
mouton29 mouton29 2 minutes ago
EYPT is planning to go ahead with sham and 6 month re-dose in a non-inferiority trial.
They said this recently at the Goldman Sachs conference. See slide 24 available here.
https://investors.eyepointpharma.com/static-files/38325b35-27bf-43fc-8370-3836e64da535.

And i
US-JUSTICE US-JUSTICE 2 minutes ago
one of the main reasons companies and individuals hide their assets in swiss banks and cayman islands is not to hide ill gotten gains or hide money and not pay taxes,
the main reason people hide their assets under various corporations is to prevent easy access to funds from fake gov't fines a
HGENQ
DimesForShares DimesForShares 3 minutes ago
There is no basis to believe that KBLB produced 25 kilos during the Spring Trials. The primary purpose of those trials was to increase the breeding pool in order to produce sufficient eggs to reach metric ton levels of production. This means breeding homozygous Bam-1 parent lines, not cross-bred h
KBLB
Steady_T Steady_T 3 minutes ago
The first thing I would say is that you used the word "fair". My considered opinion is the market is not fair.

I tried to make the distinction between long term and short term. The current share price is based on the short term view as I see it. That means, by definition, that projec
AVXL
Hosai Hosai 3 minutes ago
Investor could you try and be more specific about which points you disagreed with.
What would be your predicted revenues and market cap on approval and what would your approval % chances be for EMA/FDA?
AVXL
al44 al44 4 minutes ago
‘When You’re Hot, You’re Hot’—and Trump is hot!

By Silvio Canto, Jr.

Jerry Reed was right many years ago:

Put all the money in and let’s roll ‘em again

When you’re hot, you’re hot

It sure looks like Mr. Trump is “hot”
cjstocksup cjstocksup 4 minutes ago
https://x.com/libsoftiktok/status/1801633414468276239
XenaLives XenaLives 5 minutes ago
Talk about gibberish....

"Applying that definition to an entire industry that has
less knowledge than she IS a stretch."

Big Pharma knows they are poisoning people, they only care about the $$$$.

I know they know... and you know that I know they kn
AVXL
eagle8 eagle8 6 minutes ago
I don't have an X account dstock.
I just read there.
Also your posts overthere ( https://twitter.com/d_stock07734).

Best to you.
NWBO
cjstocksup cjstocksup 6 minutes ago
https://x.com/LibertyCappy/status/1801904730588750159
RMS555 RMS555 6 minutes ago
you won't..... this company dilutes like mad. You have to dissect the Quarterly Reports to figure out when there wont be dilution for a couple of weeks and that is if you are real good at reading the Quarterly Reports.
PPCB
Investor2014 Investor2014 6 minutes ago
I do see why those lofty fantasies (or biologist type calculations) are meaningless and WGT biased.
I don't see how you can ignore the potential valuation if it does get approved
Especially in the event that A2-73 isn't approved. I know, there is an 83% chance of EMA approval - right!
AVXL
Murphydog25 Murphydog25 6 minutes ago
Hopefully!! I would like to get a few more shares!
Have you got anything new to add spastic rodent🐀? you have been Spewing the same old news for months its certainly still got a great SS and the debt isn't excessive for a growing company its actually minimal for a pinky christ I owe
TMSH
stockinspector stockinspector 7 minutes ago
INQD is throttling up but some can't see it!
Often we will find that some traders get involved in a stock when the excitement is at its peak, only to see that energy dissipate along with price. If held even longer they may try to trade in the counter trend to recover. If that fails the natura
INQD

Your Recent History

LSE
0N5X
Adl Partner
BIT
P1QPU3
BNP Paribas Issuance
BIT
P1OKX3
BNP Paribas Issuance
BIT
RNO
Renault
BIT
P1SXF4
BNP Paribas Issuance
BIT
P1JO88
BNP Paribas Issuance BV
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved